N.C Dallob compensation by year
CHEMED Summary Compensation Table · all 3 fiscal years held| Component | FY2017 | FY2018 | FY2019 |
|---|---|---|---|
| Salary | $380,000 | $400,333 | $423,667 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $153,277 | $276,625 | $191,287 |
| Option awards | $397,922 | $483,556 | $624,465 |
| Non-equity incentive | $469,580 | $565,182 | $503,075 |
| Pension and deferred compensation | $6,179 | $6,104 | $13,404 |
| All other | $176,946 | $238,227 | $237,874 |
| Total | $1,583,904 | $1,970,027 | $1,993,772 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CHEMED CORP DEF 14A filed April 9, 2020, accession 0001157523-20-000492, and prior-year filings.
How this page was built: the CHEMED CORP filed document, accession 0001157523-20-000492. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2020.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 718 | $315,389 | — |
| RSU | 648 | $284,640 | — |
| RSU | 554 | $243,350 | — |
| Option | 8,000 | — | $413.19 |
| Option | 2,867 | — | $231.91 |
| Option | 4,800 | — | $306.70 |
Per the Outstanding Equity Awards at Fiscal Year-End table in CHEMED CORP's FY2019 proxy; value at the fiscal year-end close, as the company printed it.
CHEMED’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Kevin McNamara | President and Chief Executive Officer | $10,019,850 |
| David Williams | Executive Vice President and Chief Financial Officer | $3,954,877 |
| Nicholas Westfall | Executive Vice President | $3,213,485 |
| S.S Lee | Executive Vice President | $2,397,877 |
| N.C Dallob · this page | Vice President, Secretary and Chief Legal Officer | $1,993,772 |
The full CHEMED compensation record
free company briefThis page is one person within CHEMED's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CHEMED proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CHEMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.